Literature DB >> 17951206

Does using a higher cutoff for the percentage of positive cells improve the specificity of HER-2 immunohistochemical analysis in breast carcinoma?

Omar Hameed1, David C Chhieng, Amy L Adams.   

Abstract

This study was performed to determine whether using a 30% cutoff for the proportion of HER-2+ cells would increase the specificity of HER-2 immunohistochemical analysis. Blinded to the HER-2 amplification status, 3 pathologists retrospectively reviewed HER-2-stained sections of breast carcinoma and considered cases to be positive for protein overexpression (3+) using 3 cutoff levels, 10%, 30%, and 50%, for the proportion of cells with intense uniform staining. Of 98 cases, 27 (28%) were positive by fluorescence in situ hybridization (FISH), and 32 (33%), 28 (29%), and 26 (27%) were considered positive for overexpression using cutoffs of 10%, 30%, and 50%, respectively. The specificity values of HER-2 immunohistochemical analysis were 82%, 86%, and 87% for the different cutoffs, and the concordance rates of 3+ cases with FISH were 59%, 64%, and 65%, for the cutoffs of 10%, 30%, and 50%, respectively. These findings seem to somehow support the recently proposed American Society of Clinical Oncology/College of American Pathologists guideline recommendations for HER-2 testing; nevertheless further studies are suggested.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17951206     DOI: 10.1309/L9HQHR0798FH0LQN

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Breast carcinomas with isolated bone metastases have different hormone receptor expression profiles than those with metastases to other sites or multiple organs.

Authors:  Shi Wei; Yufeng Li; Gene P Siegal; Omar Hameed
Journal:  Ann Diagn Pathol       Date:  2010-12-16       Impact factor: 2.090

2.  Comparison of fluorescence in situ hybridization and immunohistochemistry for assessment of HER-2 status in breast cancer patients.

Authors:  Lin Wang; Xiaobei Wang; Xiu Nie; Ling Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

3.  Lysine-222 succinylation reduces lysosomal degradation of lactate dehydrogenase a and is increased in gastric cancer.

Authors:  Xiang Li; Chen Zhang; Ting Zhao; Zhongping Su; Mengjing Li; Jiancheng Hu; Jianfei Wen; Jiajia Shen; Chao Wang; Jinshun Pan; Xianmin Mu; Tao Ling; Yingchang Li; Hao Wen; Xiaoren Zhang; Qiang You
Journal:  J Exp Clin Cancer Res       Date:  2020-08-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.